Adult bronchiectasis management is evolving: 9 new recommendations

There’s no doubt that bronchiectasis is becoming more recognised in clinical practice and evidence for its treatment is evolving, but questions remain around the burden of disease in Australia and the impact of long-term macrolides on bacterial resistance, Australian respiratory physicians say. Writing in a review of the chronic lung condition published in this week’s ...

Already a member?

Login to keep reading.

© 2021 the limbic